Literature DB >> 15498038

Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells.

A M Holm1, E A Sivertsen, S H Tunheim, T Haug, V Bjerkeli, A Yndestad, P Aukrust, S S Frøland.   

Abstract

Common variable immunodeficiency (CVID) represents a heterogeneous group of antibody deficiency syndromes, characterized by defective antibody production in which T cell deficiency may play a pathogenic role. A subgroup of CVID patients has impaired in vitro T cell proliferation. Using microarray analyses of T cells from these patients, we found a gene expression pattern different from healthy controls and patients with X-linked agammaglobulinaemia. The profile of the differentially expressed genes suggests enhanced cytotoxic effector functions, antigen experienced or chronically activated T cells and a predominance of CCR7(-) T cells. Further experiments using flow cytometry revealed a striking predominance of CCR7(-) T cells in a subgroup of CVID patients, and an association with impaired T cell proliferation. Our observations indicate that a predominance of CCR7(-) T cells with effector-memory cell features and with reduced proliferative capacity may characterize a subgroup of CVID.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498038      PMCID: PMC1809214          DOI: 10.1111/j.1365-2249.2004.02630.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing.

Authors:  J J Campbell; E C Butcher
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

Review 3.  Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies.

Authors: 
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

5.  Skewed maturation of memory HIV-specific CD8 T lymphocytes.

Authors:  P Champagne; G S Ogg; A S King; C Knabenhans; K Ellefsen; M Nobile; V Appay; G P Rizzardi; S Fleury; M Lipp; R Förster; S Rowland-Jones; R P Sékaly; A J McMichael; G Pantaleo
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 6.  DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology.

Authors:  Gary S Firestein; David S Pisetsky
Journal:  Arthritis Rheum       Date:  2002-04

7.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.

Authors:  Maximilian Diehn; Ash A Alizadeh; Oliver J Rando; Chih Long Liu; Kryn Stankunas; David Botstein; Gerald R Crabtree; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

8.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.

Authors:  Christopher Lock; Guy Hermans; Rosetta Pedotti; Andrea Brendolan; Eric Schadt; Hideki Garren; Annette Langer-Gould; Samuel Strober; Barbara Cannella; John Allard; Paul Klonowski; Angela Austin; Nagin Lad; Naftali Kaminski; Stephen J Galli; Jorge R Oksenberg; Cedric S Raine; Renu Heller; Lawrence Steinman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

9.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

10.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

View more
  11 in total

1.  The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives.

Authors:  Delfien J A Bogaert; Marieke De Bruyne; Veronique Debacker; Pauline Depuydt; Katleen De Preter; Carolien Bonroy; Jan Philippé; Victoria Bordon; Bart N Lambrecht; Tessa Kerre; Andrea Cerutti; Karim Y Vermaelen; Filomeen Haerynck; Melissa Dullaers
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

2.  Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia.

Authors:  A M Holm; G Tjønnfjord; A Yndestad; K Beiske; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication.

Authors:  J K Damås; L Landrø; B Fevang; L Heggelund; G E Tjønnfjord; Y Fløisand; B Halvorsen; S S Frøland; P Aukrust
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

4.  Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.

Authors:  Sayed Mahdi Marashi; Mohammad Raeiszadeh; Sarita Workman; Afsar Rahbar; Cecilia Soderberg-Naucler; Paul Klenerman; Ronnie Chee; A David Webster; Richard S B Milne; Vincent C Emery
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

5.  Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.

Authors:  Sophie Brouard; Elaine Mansfield; Christophe Braud; Li Li; Magali Giral; Szu-chuan Hsieh; Dominique Baeten; Meixia Zhang; Joanna Ashton-Chess; Cécile Braudeau; Frank Hsieh; Alexandre Dupont; Annaik Pallier; Anne Moreau; Stéphanie Louis; Catherine Ruiz; Oscar Salvatierra; Jean-Paul Soulillou; Minnie Sarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

Review 6.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 7.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

8.  Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.

Authors:  B Fevang; A Yndestad; J K Damås; B Halvorsen; A M Holm; K Beiske; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2009-08-12       Impact factor: 4.330

9.  Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes.

Authors:  Yevgeniy A Grigoryev; Sunil M Kurian; Aleksey A Nakorchevskiy; John P Burke; Daniel Campbell; Steve R Head; Jun Deng; Aaron B Kantor; John R Yates; Daniel R Salomon
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

Review 10.  Common variable immunodeficiency: an update.

Authors:  Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.